메뉴 건너뛰기




Volumn 56, Issue JAN., 2008, Pages 47-48

Highly elevated serum CA 125 in a lady with ascites and retroperitoneal mass - A diagnostic dilemma

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CA 125 ANTIGEN; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DOXORUBICIN; DRUG DERIVATIVE; GEMCITABINE; PACLITAXEL; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

EID: 38049165821     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (9)
  • 1
    • 0141870143 scopus 로고    scopus 로고
    • Serum CA 125 as a prognostic factor in Non Hodgkin's lymphoma
    • Osnat Bairey, Dorit Blickstein. Serum CA 125 as a prognostic factor in Non Hodgkin's lymphoma. Leukemia and Lymphoma 2003;44:1733-8.
    • (2003) Leukemia and Lymphoma , vol.44 , pp. 1733-1738
    • Bairey, O.1    Blickstein, D.2
  • 2
    • 17944385313 scopus 로고    scopus 로고
    • Use fullness of the epithelial tumor marker CA 125 in non-Hodgkin's lymphoma
    • Ozguroglu Mustafa, Turna Hande, Demir Gokhan. Use fullness of the epithelial tumor marker CA 125 in non-Hodgkin's lymphoma. American Journal of Clinical Oncology 1999;22:615.
    • (1999) American Journal of Clinical Oncology , vol.22 , pp. 615
    • Mustafa, O.1    Hande, T.2    Gokhan, D.3
  • 3
    • 3543016737 scopus 로고    scopus 로고
    • Serum CA12: A tumor marker for monitoring response to treatment and follow up in patients with non-Hodgkin's lymphoma
    • Jamal Zidan, Osamah Hussein. Serum CA12: A tumor marker for monitoring response to treatment and follow up in patients with non-Hodgkin's lymphoma. The Oncologist 2004;9:417-21.
    • (2004) The Oncologist , vol.9 , pp. 417-421
    • Zidan, J.1    Hussein, O.2
  • 4
    • 0033637557 scopus 로고    scopus 로고
    • A new serologic Index for low grade non-Hodgkin's lymphoma based on initial CA 125 and LDH serum levels
    • Benboubker L. A new serologic Index for low grade non-Hodgkin's lymphoma based on initial CA 125 and LDH serum levels. Annals of Oncology 2000;11:1485-1491.
    • (2000) Annals of Oncology , vol.11 , pp. 1485-1491
    • Benboubker, L.1
  • 6
    • 0032006997 scopus 로고    scopus 로고
    • Serum CA 125 is of clinical value in the staging and follow up of patient with non-Hodgkin's lymphoma
    • Mario Lazzarino. Serum CA 125 is of clinical value in the staging and follow up of patient with non-Hodgkin's lymphoma. Cancer 2000;82:576-582.
    • (2000) Cancer , vol.82 , pp. 576-582
    • Lazzarino, M.1
  • 7
    • 34147148119 scopus 로고    scopus 로고
    • Limited usefulness of CA 125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma
    • Bonnet C, Bequin Y, Fassotte F, Seidel L, Luyckx F, Fillet G. Limited usefulness of CA 125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. Eur J Haematol 2007;78:399-404.
    • (2007) Eur J Haematol , vol.78 , pp. 399-404
    • Bonnet, C.1    Bequin, Y.2    Fassotte, F.3    Seidel, L.4    Luyckx, F.5    Fillet, G.6
  • 8
    • 0036816858 scopus 로고    scopus 로고
    • The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma
    • Ioannis D Zacharos, Stamatis P Efstathiou. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. Eru J Haematol 2002;69:221.
    • (2002) Eru J Haematol , vol.69 , pp. 221
    • Zacharos, I.D.1    Efstathiou, S.P.2
  • 9
    • 85134437687 scopus 로고    scopus 로고
    • Tanja Fehm, Eberhard Beck. CA 125 Elevations in patients with malignant lymphomas. Tumor Biology 1998;19:283-9.
    • Tanja Fehm, Eberhard Beck. CA 125 Elevations in patients with malignant lymphomas. Tumor Biology 1998;19:283-9.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.